Change of Adviser

RNS Number : 2818V

ValiRx PLC

29 October 2010

 



ValiRx Plc

("ValiRx" or the "Company")

Change of adviser

The Board of ValiRx (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, is pleased to announce the appointment of Cairn Financial Advisers LLP as Nominated Adviser and Hybridan LLP as sole broker with immediate effect.

Enquiries:-

ValiRx plc Dr. Satu Vainikka	Tel: [phone]
Cairn Financial Advisers LLP Nominated Adviser Tony Rawlinson / Liam Murray	Tel:[phone]
Hybridan LLP Broker Claire Noyce	Tel:[phone]
Peckwater PR Tarquin Edwards	Tel: [phone] [e-mail]

 

END

 

 

APPFMMZGFLVGGZM